Clostridiodes difficile associated disease risk and proton pump inhibitors in critically ill children
Solana, María José; Bustinza, Amaya; López, Jorge; López-Herce, Jesús.
Enferm. infecc. microbiol. clín. (Ed. impr.)
; 39(3): 160-161, Mar, 2021. tab
Artículo en Inglés | IBECS (España) | ID: ibc-208583
Documentos relacionados
[Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia].
Histamine Receptors in the Cross-Talk between Periphery and Brain.
Small bowel bleeding: cause and the role of endoscopy and medical therapy.
Barriers to Guideline-Based Use of Proton Pump Inhibitors to Prevent Upper Gastrointestinal Bleeding.
Prophylactic acid suppression and enteral nutrition.
Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement.
[Innovation in the therapy of hemorrhages of the upper digestive tract].
Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial.
The H<sub>4</sub> histamine receptor, a new rational neuroinflammatory target for Parkinson's disease: A commentary.
Gastrointestinal bleeding in a kidney transplant recipient.